Removal Of The Femoral Arterial Catheter
Watch:
"Removal of the Femoral Arterial Catheter: Use of Manual Compression to Establish Hemostasis," to see a vivid demonstration of a commonly used procedure for removing the femoral arterial catheter, and learn about clinical considerations that can positively or negatively impact patient outcomes.
Removal of the Femoral Arterial Catheter: 6 Steps To Success
Download the above poster summarizing the key steps in the removal of a femoral arterial catheter; always follow the protocols and policies of your own institution.
Download now >>
The FREE Adobe Acrobat Reader needs to be installed on your computer in order to view and print this document. If you do not already have this program, visit the Adobe Web site (www.adobe.com). (Note: you will be leaving the ANGIOMAX.com Web site.)
Safety Considerations
ANGIOMAX with provisional use of glycoprotein IIb/IIIa inhibitor is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), and in patients with or at risk for heparin-induced thrombocytopenia and thrombosis syndrome (HIT/HITTS) undergoing PCI. ANGIOMAX is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin. ANGIOMAX is contraindicated in patients with active major bleeding or hypersensitivity to ANGIOMAX or its components. The most common (
10%) adverse events for ANGIOMAX were back pain, pain, nausea, headache, and hypotension. An unexplained fall in blood pressure or hematocrit, or any unexplained symptom, should lead to serious consideration of a hemorrhagic event and cessation of ANGIOMAX administration. Please see complete
prescribing information.